Valuation: WntResearch AB

Market Cap 127M 13.38M 11.59M 10.8M 9.94M 18.76M 1.27B 18.97M 49.83M 637M 50.26M 49.16M 2.11B P/E 2024 *
-
P/E 2025 -4.79x
Enterprise Value 127M 13.4M 11.61M 10.82M 9.95M 18.79M 1.27B 19M 49.91M 638M 50.34M 49.23M 2.11B EV / Sales 2024 *
-
EV / Sales 2025 8,542,354x
Free-Float
1.03%
Yield 2024 *
-
Yield 2025 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.35%-13.20% - - 13.3M
+4.35%+19.90%+60.59%+95.21% 62.53B
+2.83%-3.48%+24.97%+69.33% 52.43B
-0.49%-2.11%-18.08%-7.62% 23.1B
+1.45%-2.56%-9.97%+359.44% 21.4B
+0.40%+5.29%+30.11%-9.63% 21.17B
+0.75%+1.34%+32.22%-25.54% 17.76B
+9.88%+19.73%+229.67%+385.49% 15.47B
+2.08%-3.28%+21.67%+564.59% 14.68B
-0.31%+1.39%+49.76%+177.04% 14.08B
Average +2.43%+3.65%+46.77%+178.70% 26.96B
Weighted average by Cap. +2.64%+4.59%+42.23%+136.80%

Financials

2024 2025
Net sales - 9.68 1.02 0.88 0.82 0.76 1.43 97.05 1.45 3.8 48.56 3.83 3.75 160.82
Net income -46.5M -4.9M -4.25M -3.96M -3.64M -6.87M -466M -6.95M -18.25M -233M -18.41M -18M -772M -17.23M -1.82M -1.57M -1.47M -1.35M -2.55M -173M -2.57M -6.76M -86.41M -6.82M -6.67M -286M
Net Debt -5.26M -554K -480K -447K -412K -777K -52.7M -786K -2.06M -26.37M -2.08M -2.04M -87.33M 185K 19.5K 16.89K 15.74K 14.48K 27.34K 1.85M 27.64K 72.61K 928K 73.24K 71.62K 3.07M
Logo WntResearch AB
Opsy Holding AB, formerly WntResearch AB, is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process.
Employees
7